喘中的生物标志物,治疗干预的可能性
M Asghar Pasha1, Russell J Hopp2, Nazia Habib3
1Department of Medicine, Division of Allergy and Immunology, Albany Medical College, Albany, NY, USA.
概括
生物标志物有助于将喘分为T2高和T2低的炎症类型,指导个性化治疗. 经过验证的生物标志物,如液异敏症,有助于识别可能受益于向治疗的患者,包括生物药物.
科学领域:
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
- 生物标志物研究 生物标志物研究
背景情况:
- 喘是一种复杂的呼吸系统疾病,具有不同的表型和炎症途径.
- 了解T2高 (eosinophilic) 和T2低的炎症对于有效的喘管理至关重要.
- 生物标志物对于识别喘亚型和预测治疗反应至关重要.
研究的目的:
- 审查生物标志物在区分T2高和T2低喘表型中的作用.
- 讨论生物标志物的临床实用性,以指导治疗决策,特别是对于生物疗法.
- 突出验证的生物标志物对个性化喘护理的重要性.
主要方法:
- 关于喘T2炎症的当前研究的综述.
- 分析与T2高和T2低喘相关的生物标志物.
- 关于验证的生物标志物及其临床应用的讨论.
主要成果:
- 高T2喘的特征是2型细胞因子 (IL-4,IL-5,IL-13),乙素,以及高FeNO.
- 低T2喘缺乏明确的定义,但代表了一个独特的内型.
- 唾液乙素是经过验证的生物标志物,表明皮质类固醇反应或不合规.
结论:
- 生物标志物对于喘的表型和指导使用生物药物等向治疗方法至关重要.
- 需要验证的生物标志物来优化治疗选择和改善患者的治疗结果.
- 最终目标是通过先进的生物标志物发现和应用,为所有喘患者提供个性化的护理.
相关概念视频
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
273
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
273
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Antiasthma Drugs: β2-Adrenoceptor Agonists
250
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
250
Asthma: Pathogenesis and Management
388
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
388
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Drugs Used in Lower Respiratory Disorders: Overview
421
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
421


